Related Experiment Video

Updated: Apr 10, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

1.2K

[Diabetes in old age: HbA1c - and then what?]

Andrej Zeyfang1

  • 1Klinik für Innere Medizin und Geriatrie, Agaplesion Bethesda Krankenhaus Stuttgart.

Deutsche Medizinische Wochenschrift (1946)
|June 13, 2015
PubMed

Insights

Glycated hemoglobin (HbA1c) levels can be unreliable in older adults due to varying red blood cell lifespans. Higher HbA1c targets are common, but hypoglycemia risk remains a concern, especially impacting cognitive function.

Area of Science:

  • Gerontology
  • Endocrinology
  • Diabetes Mellitus Research

Background:

  • Glycated hemoglobin (HbA1c) is a standard marker for assessing long-term glycemic control in diabetes.
  • Erythrocyte half-life variations in elderly individuals can compromise HbA1c accuracy.
  • Current clinical practice often employs higher HbA1c targets for older diabetic patients.

Purpose of the Study:

  • To evaluate the reliability of HbA1c in older adults with diabetes.
  • To highlight the persistent risk of hypoglycemia despite elevated HbA1c levels in this population.
  • To emphasize the importance of functional status, particularly cognitive function, in setting individualized glycemic targets.

Main Methods:

  • Review of existing literature on HbA1c validity in aging populations.
  • Analysis of factors affecting erythrocyte lifespan and their impact on HbA1c.
  • Discussion of clinical implications for diabetes management in the elderly.

Main Results:

  • Erythrocyte lifespan alterations in the elderly can lead to inaccurate HbA1c readings.
  • Elevated HbA1c levels do not preclude the risk of hypoglycemia in older individuals.
  • Cognitive function is a critical factor to consider when determining safe and effective glycemic control goals.

Conclusions:

  • HbA1c may be a less reliable indicator of metabolic control in the elderly.
  • Hypoglycemia risk must be carefully assessed in older adults with diabetes, irrespective of HbA1c values.
  • Individualized treatment strategies prioritizing functional status and minimizing hypoglycemia are essential for geriatric diabetes care.

More Related Videos

Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K
Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test06:59

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test

Published on: November 13, 2016

11.5K

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.9K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.8K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
15.1K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
350
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
326
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
331